Diabetologia:得糖尿病越早,死于癌症,中风等的风险越大吗?

2018-02-27 佚名 Medicalxpress

在Diabetologia杂志上发表的一项研究发现,一个人被诊断患有糖尿病的年龄与其患有心脏病,中风和癌症相关死亡率的风险之间存在一些有趣的关联。

在Diabetologia杂志上发表的一项研究发现,一个人被诊断患有糖尿病的年龄与其患有心脏病,中风和癌症相关死亡率的风险之间存在一些有趣的关联。

正如最近的研究指出的那样,美国年轻人中新诊断的1型糖尿病和2型糖尿病的发病率一直在上升。

根据“新英格兰医学杂志”发布的2017年报告,20岁以下的美国约有208,000人被诊断患有糖尿病。

某人被诊断患有糖尿病的年龄与心脏代谢风险因素的进展有关。在诊断时年龄越小,人越容易肥胖,具有更高水平的“坏”胆固醇,并且血糖控制会更快恶化。

现在,来自澳大利亚墨尔本贝克心脏和糖尿病研究所的Dianna Magliano和Jonathan Shaw着手调查糖尿病诊断年龄与心脏病,中风和癌症死亡风险之间的关系。

血管死亡风险较高

为此,马利亚诺教授和研究小组审查了1997年至2011年间被诊断为2型糖尿病的743,709人。

由于这些人都是在澳大利亚的国家糖尿病服务计划中注册的,研究人员可以获得有关死亡原因的数据。

平均而言,在研究期间,人们在59岁时得到诊断,共记录了115,363人死亡。

“因此,”他们继续说道,“对于早发型2型糖尿病患者来说,增加临床注意力是必不可少的。”

研究人员补充说:“工作重点应放在及时优化个人自我管理技能和药物治疗,以预防或减少并发症和合并症的发生。”

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1760554, encodeId=88d21e60554b9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Dec 21 05:41:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638435, encodeId=30ab1638435e3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jan 10 00:41:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291368, encodeId=4fa129136840, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Tue Feb 27 09:51:59 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291364, encodeId=e54929136446, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Tue Feb 27 09:50:43 CST 2018, time=2018-02-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1760554, encodeId=88d21e60554b9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Dec 21 05:41:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638435, encodeId=30ab1638435e3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jan 10 00:41:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291368, encodeId=4fa129136840, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Tue Feb 27 09:51:59 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291364, encodeId=e54929136446, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Tue Feb 27 09:50:43 CST 2018, time=2018-02-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1760554, encodeId=88d21e60554b9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Dec 21 05:41:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638435, encodeId=30ab1638435e3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jan 10 00:41:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291368, encodeId=4fa129136840, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Tue Feb 27 09:51:59 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291364, encodeId=e54929136446, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Tue Feb 27 09:50:43 CST 2018, time=2018-02-27, status=1, ipAttribution=)]
    2018-02-27 sunfeifeiyang

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1760554, encodeId=88d21e60554b9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Fri Dec 21 05:41:00 CST 2018, time=2018-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638435, encodeId=30ab1638435e3, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jan 10 00:41:00 CST 2019, time=2019-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291368, encodeId=4fa129136840, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Tue Feb 27 09:51:59 CST 2018, time=2018-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=291364, encodeId=e54929136446, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Tue Feb 27 09:50:43 CST 2018, time=2018-02-27, status=1, ipAttribution=)]
    2018-02-27 紫迎馨

    学习

    0

相关资讯

Lancet Diabetes Endo:非诺贝特可降低II型糖尿病患者尿酸浓度,降低痛风发作风险

5年的长期研究认为,非诺贝特可降低20%的尿酸浓度,减少50%的痛风发作风险。非诺贝特可作为预防糖尿病痛风的有效辅助手段

Diabetes:研究发现,治疗糖尿病并发症的新方法

最近的研究结果提出了一种新的方法来保护糖尿病患者免受晚期血管疾病的高风险。

J Clin Periodontol:RANKL的表达在实验性牙周炎中的作用

牙周炎是由细菌引起的炎症。一种关键的细胞因子RANKL与其相关,而目前尚未建立对牙周炎至关重要的RANKL的细胞来源。

J Clin Periodontol:WNT/β-catenin信号拮抗剂在2型糖尿病和吸烟相关牙周炎中的作用

本研究评估了与2型糖尿病(DM)和/或吸烟相关的慢性牙周炎(CP)中硬化蛋白(SOST)和Dickkopf(DKK)-1的水平。评估SOST,DDK1,RANKL,OPG,IL-1β,IL-6和TNF-α与病原体之间的关系。

JACC:冠脉搭桥治疗伴有糖尿病和左心功能不全的冠心病患者效果更佳

经皮冠脉介入术(PCI)和冠脉搭桥术(CABG)在多血管冠脉病变(CAD)及糖尿病患者中的应用已经被大量报道,但是这些临床研究大部分均排除了左室功能不全(LVD)的患者。本研究的目的旨在评估PCI或者CABG是否会改善CAD伴糖尿病和LVD患者的预后。本研究的主要终点事件是主要不良心脑血管疾病事件的发生,包括死亡、卒中、心梗和反复的血管再生的复合发生率。结果显示,相比于CABG组患者,PCI组患者

Diabetes Care:非诺贝特对2型糖尿病患者心血管风险的预测作用!

在一些临床试验结果中显示,非诺贝特治疗并不能降低2型糖尿病(T2DM)患者主要心血管事件(MCVE)的发生率。然而,这些试验报告的治疗效果包括了治疗不良反应的患者和对非诺贝特反应良好的患者。近期,一项发表在杂志Diabetes Care上的研究旨在使用统计建模来评估非诺贝特对个体2型糖尿病患者的预期治疗效果。为了估计个体风险,将5年MCVE作为主要结果的FIELD风险模型在来自ACCORD和SMA